SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
IMNR - Immune Response
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
1510 20 0 IMNR
Emcee:  Nagaraju R. Arakotaram Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
360 GILD was up big on news that Preveon, its anti-viral drug, is effective in combEasy Mark-4/6/1998
359 Top ten reasons to be long IMNR: 1. Remune has a probability-weighted value 5Easy Mark-4/6/1998
358 Top ten reasons to short IMNR: 1. IRC insiders tend to sell at the peak as theEasy Mark-4/6/1998
357 good to hear your comments blue especially comming from a large holder that hasManny Gugliuzza-4/6/1998
356 Easy Mark...Just go to YAHOO quotes, when you pull up an individual quote, you BLUE HORSE SHOE-4/6/1998
355 BHS: Thanks for the Yahoo posts. How do I locate them directly? The respondentEasy Mark-4/6/1998
354 Part 3 HORSESHOE98 Apr 1 1998 9:04PM EST Unfortunately I think that many long tBLUE HORSE SHOE-4/5/1998
353 Part 2 HORSESHOE98 Apr 1 1998 8:57PM EST I am concerned that investors may be sBLUE HORSE SHOE-4/5/1998
352 I posted a three part message on the YAHOO message board, and it has generated BLUE HORSE SHOE-4/5/1998
351 I just received the most recent Individual Investor magazine (May 98) and it haGreed Is Good-4/4/1998
350 I was avoiding saying that CEGE's approach is flawed because I do not know.Easy Mark-4/4/1998
349 Easy Mark; You obviously know much more of this subject than I do, however I dSteve Lokness-4/3/1998
348 RD: I went back to look at the terms of their purchase agreement, which followsEasy Mark-4/3/1998
347 hopefully it will not be too long after the Sept completion of phase II combinManny Gugliuzza-4/3/1998
346 Is this week's NEJM editorial positive or negative for Remune? The NEJM puEasy Mark-4/3/1998
345 This is my best comparison of T-cell technologies of Cell Genesys (CEGE) and IEasy Mark-4/3/1998
344 Almost all spending on aids patients is US, Europe and Japan. In Asia and AfriEasy Mark-4/3/1998
343 It is my understanding that the USA has 10% of the world's aids population.jake burns-4/3/1998
342 Keep in mind that the tax law changed after the stock purchase. I think the orEasy Mark-4/3/1998
341 EM: I read the 10K and did not realize that that was the case. Thanks for poiRobert DeHaven-4/3/1998
340 Early approval of Remune requires a showing of therapudic gain. Since Remune dEasy Mark-4/2/1998
339 cusip # is 45252T106 they are out of CA. and PA. sorry. check the name spelliManny Gugliuzza-4/2/1998
338 The stock I have is Immune Response, Inc. CUSIP 452917107 Some shady company fCraig E. Witt-4/1/1998
337 any reason for not having a luck day in Oct or Nov of 1991 Craig? ar.Manny Gugliuzza-4/1/1998
336 I took a small position last week but we are real close to my mental stop loss Texas77-4/1/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News